Evidence map›Paper›PMID 29201547›Full record

ArticleBrain and behavior2017

Decremental responses in patients with motor neuron disease.

Mohammed H Alanazy, Janka Hegedus, Chris White, Lawrence Korngut

Abstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. CMAP decrement by low-frequency repetitive nerve stimulation in different hand muscles of ALS patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammed H AlanazyDepartment of Internal Medicine King Saud University Medical City and College of Medicine King Saud University Riyadh Saudi Arabia.ORCID 0000-0001-5177-8283
Janka HegedusDivision of Neuromuscular Department of Clinical Neurosciences University of Calgary Calgary Alberta Canada.
Chris WhiteDivision of Neuromuscular Department of Clinical Neurosciences University of Calgary Calgary Alberta Canada.
Lawrence KorngutDivision of Neuromuscular Department of Clinical Neurosciences University of Calgary Calgary Alberta Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Involvement of the neuromuscular junction (NMJ) in amyotrophic lateral sclerosis (ALS) has been reported and is increasingly recognized as an important pathophysiological aspect. The relationship between decrement and clinical measures for possible application as a biomarker has not been comprehensively explored. Methods: We performed routine repetitive nerve stimulation (RNS) of three nerves on patients with ALS. We captured measures of muscle strength, grip strength, fatigability, and calculated slow vital capacity (SVC) rates of change assessing for associations. Results: In 42 subjects, 210 muscles were studied. Negative correlation was found between the percentage of decrement and compound muscle action potential (CMAP) amplitude. Approximately half of the patients with hand weakness did not have decrement. There was no significant correlation between decrement and handgrip fatigue, SVC < 80% predicted, or more rapid worsening of SVC over time. Conclusions: Abnormal decremental responses are well described in ALS. We report that the degree of decremental response does not correlate with the degree of weakness. Abnormal decrement is only rarely present in nerve-muscle pairs with normal motor power. Our findings did not support a correlation between abnormal decrement and clinical measures suggesting that RNS may not be useful as a biomarker to monitor ALS progression.

Indexed as

Amyotrophic Lateral SclerosisAction PotentialsAgedDisease ProgressionElectric StimulationFemaleHumansMaleMiddle AgedMuscle StrengthMuscle WeaknessMuscular AtrophyNeuromuscular JunctionReproducibility of Resultsamyotrophic lateral sclerosismotor neuron diseaseneuromuscular junctionprogressive muscular atrophyrepetitive nerve stimulation

Identifiers

PMID29201547
PMCPMC5698864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.